BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Openshaw PJ, Tregoning JS. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev 2005;18:541-55. [PMID: 16020689 DOI: 10.1128/CMR.18.3.541-555.2005] [Cited by in Crossref: 209] [Cited by in F6Publishing: 113] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Pickens JA, Tripp RA. Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses. Viruses 2018;10:E48. [PMID: 29361733 DOI: 10.3390/v10010048] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
2 Vojvoda V, Savić Mlakar A, Jergović M, Kukuruzović M, Markovinović L, Aberle N, Rabatić S, Bendelja K. The increased type-1 and type-2 chemokine levels in children with acute RSV infection alter the development of adaptive immune responses. Biomed Res Int 2014;2014:750521. [PMID: 25013801 DOI: 10.1155/2014/750521] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
3 Bohmwald K, Espinoza JA, Rey-Jurado E, Gómez RS, González PA, Bueno SM, Riedel CA, Kalergis AM. Human Respiratory Syncytial Virus: Infection and Pathology. Semin Respir Crit Care Med 2016;37:522-37. [PMID: 27486734 DOI: 10.1055/s-0036-1584799] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
4 Muenchhoff M, Goulder PJ. Sex differences in pediatric infectious diseases. J Infect Dis 2014;209 Suppl 3:S120-6. [PMID: 24966192 DOI: 10.1093/infdis/jiu232] [Cited by in Crossref: 140] [Cited by in F6Publishing: 131] [Article Influence: 17.5] [Reference Citation Analysis]
5 Schmidt ME, Varga SM. Identification of Novel Respiratory Syncytial Virus CD4+ and CD8+ T Cell Epitopes in C57BL/6 Mice. Immunohorizons 2019;3:1-12. [PMID: 31356172 DOI: 10.4049/immunohorizons.1800056] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Currie SM, Gwyer Findlay E, McFarlane AJ, Fitch PM, Böttcher B, Colegrave N, Paras A, Jozwik A, Chiu C, Schwarze J, Davidson DJ. Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans. J Immunol 2016;196:2699-710. [PMID: 26873992 DOI: 10.4049/jimmunol.1502478] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 12.0] [Reference Citation Analysis]
7 Mansbach JM, Piedra PA, Laham FR, McAdam AJ, Clark S, Sullivan AF, Camargo CA Jr. Nasopharyngeal lactate dehydrogenase concentrations predict bronchiolitis severity in a prospective multicenter emergency department study. Pediatr Infect Dis J 2012;31:767-9. [PMID: 22517336 DOI: 10.1097/INF.0b013e3182565eae] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
8 Sampayo-Escobar V, Green R, Cheung MB, Bedi R, Mohapatra S, Mohapatra SS. Osteopontin plays a pivotal role in increasing severity of respiratory syncytial virus infection. PLoS One 2018;13:e0192709. [PMID: 29677209 DOI: 10.1371/journal.pone.0192709] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yamaguchi Y, Harker JA, Wang B, Openshaw PJ, Tregoning JS, Culley FJ. Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection. J Virol 2012;86:10456-61. [PMID: 22811525 DOI: 10.1128/JVI.01082-12] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
10 Pribul PK, Harker J, Wang B, Wang H, Tregoning JS, Schwarze J, Openshaw PJ. Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development. J Virol 2008;82:4441-8. [PMID: 18287232 DOI: 10.1128/JVI.02541-07] [Cited by in Crossref: 130] [Cited by in F6Publishing: 98] [Article Influence: 9.3] [Reference Citation Analysis]
11 Lee J, Klenow L, Coyle EM, Golding H, Khurana S. Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains. PLoS Pathog 2018;14:e1007262. [PMID: 30142227 DOI: 10.1371/journal.ppat.1007262] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
12 Katzov-Eckert H, Botosso VF, Neto EA, Zanotto PM; VGND consortium. Phylodynamics and dispersal of HRSV entails its permanence in the general population in between yearly outbreaks in children. PLoS One 2012;7:e41953. [PMID: 23077477 DOI: 10.1371/journal.pone.0041953] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
13 McGinnes LW, Gravel KA, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Schmidt MR, Morrison TG. Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins. J Virol 2011;85:366-77. [PMID: 20980510 DOI: 10.1128/JVI.01861-10] [Cited by in Crossref: 75] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
14 Schotsaert M, Ibañez LI, Fiers W, Saelens X. Controlling influenza by cytotoxic T-cells: calling for help from destroyers. J Biomed Biotechnol 2010;2010:863985. [PMID: 20508820 DOI: 10.1155/2010/863985] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
15 Kinnear E, Lambert L, McDonald JU, Cheeseman HM, Caproni LJ, Tregoning JS. Airway T cells protect against RSV infection in the absence of antibody. Mucosal Immunol 2018;11:249-56. [PMID: 28537249 DOI: 10.1038/mi.2017.46] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
16 Huisman W, Martina BE, Rimmelzwaan GF, Gruters RA, Osterhaus AD. Vaccine-induced enhancement of viral infections. Vaccine 2009;27:505-12. [PMID: 19022319 DOI: 10.1016/j.vaccine.2008.10.087] [Cited by in Crossref: 116] [Cited by in F6Publishing: 109] [Article Influence: 8.3] [Reference Citation Analysis]
17 Bawage SS, Tiwari PM, Pillai S, Dennis V, Singh SR. Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus. Adv Virol 2013;2013:595768. [PMID: 24382964 DOI: 10.1155/2013/595768] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
18 Piedra FA, Mei M, Avadhanula V, Mehta R, Aideyan L, Garofalo RP, Piedra PA. The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis. PLoS One 2017;12:e0172953. [PMID: 28267794 DOI: 10.1371/journal.pone.0172953] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
19 Percopo CM, Qiu Z, Phipps S, Foster PS, Domachowske JB, Rosenberg HF. Pulmonary eosinophils and their role in immunopathologic responses to formalin-inactivated pneumonia virus of mice. J Immunol 2009;183:604-12. [PMID: 19542471 DOI: 10.4049/jimmunol.0802270] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
20 Riffault S, Meyer G, Deplanche M, Dubuquoy C, Durand G, Soulestin M, Castagné N, Bernard J, Bernardet P, Dubosclard V, Bernex F, Petit-Camurdan A, Deville S, Schwartz-Cornil I, Eléouët JF. A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus. Vaccine 2010;28:3722-34. [PMID: 20307593 DOI: 10.1016/j.vaccine.2010.03.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
21 Harker J, Bukreyev A, Collins PL, Wang B, Openshaw PJ, Tregoning JS. Virally delivered cytokines alter the immune response to future lung infections. J Virol 2007;81:13105-11. [PMID: 17855518 DOI: 10.1128/JVI.01544-07] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
22 Canedo-Marroquín G, Acevedo-Acevedo O, Rey-Jurado E, Saavedra JM, Lay MK, Bueno SM, Riedel CA, Kalergis AM. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity. Front Cell Infect Microbiol 2017;7:367. [PMID: 28861397 DOI: 10.3389/fcimb.2017.00367] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
23 Olszewska W, Openshaw P. Emerging drugs for respiratory syncytial virus infection. Expert Opin Emerg Drugs 2009;14:207-17. [PMID: 19453286 DOI: 10.1517/14728210902946399] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
24 Krause A, Xu Y, Ross S, Wu W, Joh J, Worgall S. Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine. Virol J 2011;8:375. [PMID: 21801372 DOI: 10.1186/1743-422X-8-375] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
25 Du X, Yang Y, Xiao G, Yang M, Yuan L, Qin L, He R, Wang L, Wu M, Wu S, Feng J, Xiang Y, Qu X, Liu H, Qin X, Liu C. Respiratory syncytial virus infection-induced mucus secretion by down-regulation of miR-34b/c-5p expression in airway epithelial cells. J Cell Mol Med 2020;24:12694-705. [PMID: 32939938 DOI: 10.1111/jcmm.15845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
26 Reichert JM. Trends in the development and approval of monoclonal antibodies for viral infections. BioDrugs 2007;21:1-7. [PMID: 17263584 DOI: 10.2165/00063030-200721010-00001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
27 Yoshida I, Arikawa K, Honma Y, Inatani S, Yoshinaga M, Sugiyama H. Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants. Antimicrob Agents Chemother 2020;65:e01407-20. [PMID: 33046486 DOI: 10.1128/AAC.01407-20] [Reference Citation Analysis]
28 Zhang Q, Li S, Huang Q. Pratensein glycoside attenuates respiratory syncytial virus infection-induced oxidative and inflammatory injury via TGF-β signaling pathway. Mol Cell Toxicol . [DOI: 10.1007/s13273-021-00200-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Sutton TC, Scott MD. The effect of grafted methoxypoly(ethylene glycol) chain length on the inhibition of respiratory syncytial virus (RSV) infection and proliferation. Biomaterials 2010;31:4223-30. [PMID: 20153523 DOI: 10.1016/j.biomaterials.2010.01.095] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
30 McFarlane AJ, McSorley HJ, Davidson DJ, Fitch PM, Errington C, Mackenzie KJ, Gollwitzer ES, Johnston CJC, MacDonald AS, Edwards MR, Harris NL, Marsland BJ, Maizels RM, Schwarze J. Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota. J Allergy Clin Immunol 2017;140:1068-1078.e6. [PMID: 28196762 DOI: 10.1016/j.jaci.2017.01.016] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 10.6] [Reference Citation Analysis]
31 Harker JA, Godlee A, Wahlsten JL, Lee DC, Thorne LG, Sawant D, Tregoning JS, Caspi RR, Bukreyev A, Collins PL, Openshaw PJ. Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells. J Virol 2010;84:4073-82. [PMID: 20130064 DOI: 10.1128/JVI.02014-09] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
32 Holgado MP, Raiden S, Sananez I, Seery V, De Lillo L, Maldonado LL, Kamenetzky L, Geffner J, Arruvito L. Fcγ Receptor IIa (FCGR2A) Polymorphism Is Associated With Severe Respiratory Syncytial Virus Disease in Argentinian Infants. Front Cell Infect Microbiol 2020;10:607348. [PMID: 33392111 DOI: 10.3389/fcimb.2020.607348] [Reference Citation Analysis]
33 Vissers M, Habets MN, Ahout IM, Jans J, de Jonge MI, Diavatopoulos DA, Ferwerda G. An in vitro model to study immune responses of human peripheral blood mononuclear cells to human respiratory syncytial virus infection. J Vis Exp 2013;:e50766. [PMID: 24379004 DOI: 10.3791/50766] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
34 Culley FJ, Pennycook AM, Tregoning JS, Dodd JS, Walzl G, Wells TN, Hussell T, Openshaw PJ. Role of CCL5 (RANTES) in viral lung disease. J Virol 2006;80:8151-7. [PMID: 16873271 DOI: 10.1128/JVI.00496-06] [Cited by in Crossref: 74] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
35 Yim KC, Cragin RP, Boukhvalova MS, Blanco JC, Hamlin ME, Boivin G, Porter DD, Prince GA. Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged. Vaccine 2007;25:5034-40. [PMID: 17543425 DOI: 10.1016/j.vaccine.2007.04.075] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
36 Scott MA, Woolums AR, Swiderski CE, Perkins AD, Nanduri B, Smith DR, Karisch BB, Epperson WB, Blanton JR. Comprehensive at-arrival transcriptomic analysis of post-weaned beef cattle uncovers type I interferon and antiviral mechanisms associated with bovine respiratory disease mortality. PLoS One 2021;16:e0250758. [PMID: 33901263 DOI: 10.1371/journal.pone.0250758] [Reference Citation Analysis]
37 Stittelaar KJ, de Waal L, van Amerongen G, Veldhuis Kroeze EJ, Fraaij PL, van Baalen CA, van Kampen JJ, van der Vries E, Osterhaus AD, de Swart RL. Ferrets as a Novel Animal Model for Studying Human Respiratory Syncytial Virus Infections in Immunocompetent and Immunocompromised Hosts. Viruses 2016;8:E168. [PMID: 27314379 DOI: 10.3390/v8060168] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
38 Dourcy M, Maquet C, Dams L, Gilliaux G, Javaux J, Desmecht D, Mack M, Dewals BG, Machiels B, Gillet L. A gammaherpesvirus licenses CD8 T cells to protect the host from pneumovirus-induced immunopathologies. Mucosal Immunol 2020;13:799-813. [PMID: 32424182 DOI: 10.1038/s41385-020-0293-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Roux X, Dubuquoy C, Durand G, Tran-Tolla TL, Castagné N, Bernard J, Petit-Camurdan A, Eléouët JF, Riffault S. Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus. PLoS One 2008;3:e1766. [PMID: 18335041 DOI: 10.1371/journal.pone.0001766] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
40 Tregoning JS, Brown ES, Cheeseman HM, Flight KE, Higham SL, Lemm NM, Pierce BF, Stirling DC, Wang Z, Pollock KM. Vaccines for COVID-19. Clin Exp Immunol 2020;202:162-92. [PMID: 32935331 DOI: 10.1111/cei.13517] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 23.0] [Reference Citation Analysis]
41 Lambert L, Sagfors AM, Openshaw PJ, Culley FJ. Immunity to RSV in Early-Life. Front Immunol 2014;5:466. [PMID: 25324843 DOI: 10.3389/fimmu.2014.00466] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 12.1] [Reference Citation Analysis]
42 Park MS, Kim JI, Lee I, Park S, Bae JY, Park MS. Towards the Application of Human Defensins as Antivirals. Biomol Ther (Seoul) 2018;26:242-54. [PMID: 29310427 DOI: 10.4062/biomolther.2017.172] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
43 Martín-Vicente M, González-Sanz R, Cuesta I, Monzón S, Resino S, Martínez I. Downregulation of A20 Expression Increases the Immune Response and Apoptosis and Reduces Virus Production in Cells Infected by the Human Respiratory Syncytial Virus. Vaccines (Basel) 2020;8:E100. [PMID: 32102364 DOI: 10.3390/vaccines8010100] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Boxus M, Tignon M, Roels S, Toussaint JF, Walravens K, Benoit MA, Coppe P, Letesson JJ, Letellier C, Kerkhofs P. DNA immunization with plasmids encoding fusion and nucleocapsid proteins of bovine respiratory syncytial virus induces a strong cell-mediated immunity and protects calves against challenge. J Virol 2007;81:6879-89. [PMID: 17459933 DOI: 10.1128/JVI.00502-07] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
45 Wang S, Liu P, Yang P, Zheng J, Zhao D. Peripheral blood microRNAs expression is associated with infant respiratory syncytial virus infection. Oncotarget 2017;8:96627-35. [PMID: 29228557 DOI: 10.18632/oncotarget.19364] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
46 Tregoning JS, Pribul PK, Pennycook AM, Hussell T, Wang B, Lukacs N, Schwarze J, Culley FJ, Openshaw PJ. The chemokine MIP1alpha/CCL3 determines pathology in primary RSV infection by regulating the balance of T cell populations in the murine lung. PLoS One 2010;5:e9381. [PMID: 20195359 DOI: 10.1371/journal.pone.0009381] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
47 Wong TM, Petrovsky N, Bissel SJ, Wiley CA, Ross TM. Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology. Hum Vaccin Immunother 2016;12:2096-105. [PMID: 27215855 DOI: 10.1080/21645515.2016.1162931] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
48 Schmidt MR, McGinnes LW, Kenward SA, Willems KN, Woodland RT, Morrison TG. Long-term and memory immune responses in mice against Newcastle disease virus-like particles containing respiratory syncytial virus glycoprotein ectodomains. J Virol 2012;86:11654-62. [PMID: 22896618 DOI: 10.1128/JVI.01510-12] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
49 Schmidt MR, McGinnes-Cullen LW, Kenward SA, Willems KN, Woodland RT, Morrison TG. Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory. J Virol 2014;88:10165-76. [PMID: 24965456 DOI: 10.1128/JVI.01250-14] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
50 Culley FJ, Pennycook AM, Tregoning JS, Hussell T, Openshaw PJ. Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology. J Virol 2006;80:4521-7. [PMID: 16611912 DOI: 10.1128/JVI.80.9.4521-4527.2006] [Cited by in Crossref: 70] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
51 You D, Siefker DT, Shrestha B, Saravia J, Cormier SA. Building a better neonatal mouse model to understand infant respiratory syncytial virus disease. Respir Res 2015;16:91. [PMID: 26231396 DOI: 10.1186/s12931-015-0244-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
52 Bose B, Kapoor S, Nihad M. Induced Pluripotent Stem Cell Derived Human Lung Organoids to Map and Treat the SARS-CoV2 Infections In Vitro. Adv Exp Med Biol 2021;1312:1-17. [PMID: 33385178 DOI: 10.1007/5584_2020_613] [Reference Citation Analysis]
53 Kim CK, Callaway Z, Gern JE. Viral Infections and Associated Factors That Promote Acute Exacerbations of Asthma. Allergy Asthma Immunol Res 2018;10:12-7. [PMID: 29178673 DOI: 10.4168/aair.2018.10.1.12] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 8.5] [Reference Citation Analysis]
54 Brand HK, Ahout IM, de Ridder D, van Diepen A, Li Y, Zaalberg M, Andeweg A, Roeleveld N, de Groot R, Warris A, Hermans PW, Ferwerda G, Staal FJ. Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection. PLoS One 2015;10:e0131927. [PMID: 26162090 DOI: 10.1371/journal.pone.0131927] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
55 Murata Y. Respiratory syncytial virus vaccine development. Clin Lab Med 2009;29:725-39. [PMID: 19892231 DOI: 10.1016/j.cll.2009.07.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
56 Owczarczyk AB, Schaller MA, Reed M, Rasky AJ, Lombard DB, Lukacs NW. Sirtuin 1 Regulates Dendritic Cell Activation and Autophagy during Respiratory Syncytial Virus-Induced Immune Responses. J Immunol 2015;195:1637-46. [PMID: 26157176 DOI: 10.4049/jimmunol.1500326] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
57 Lukacs NW, Malinczak CA. Harnessing Cellular Immunity for Vaccination against Respiratory Viruses. Vaccines (Basel) 2020;8:783. [PMID: 33371275 DOI: 10.3390/vaccines8040783] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
58 Ribeiro LZ, Tripp RA, Rossi LM, Palma PV, Yokosawa J, Mantese OC, Oliveira TF, Nepomuceno LL, Queiróz DA. Serum mannose-binding lectin levels are linked with respiratory syncytial virus (RSV) disease. J Clin Immunol 2008;28:166-73. [PMID: 17952574 DOI: 10.1007/s10875-007-9141-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
59 van Erp EA, Luytjes W, Ferwerda G, van Kasteren PB. Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease. Front Immunol 2019;10:548. [PMID: 30967872 DOI: 10.3389/fimmu.2019.00548] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 22.7] [Reference Citation Analysis]
60 Ternette N, Stefanou D, Kuate S, Uberla K, Grunwald T. Expression of RNA virus proteins by RNA polymerase II dependent expression plasmids is hindered at multiple steps. Virol J 2007;4:51. [PMID: 17550613 DOI: 10.1186/1743-422X-4-51] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
61 Farhadi N, Lambert L, Triulzi C, Openshaw PJ, Guerra N, Culley FJ. Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation. J Allergy Clin Immunol 2014;133:827-35.e3. [PMID: 24290277 DOI: 10.1016/j.jaci.2013.09.048] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
62 Sarmiento RE, Tirado RG, Valverde LE, Gómez-Garcia B. Kinetics of antibody-induced modulation of respiratory syncytial virus antigens in a human epithelial cell line. Virol J 2007;4:68. [PMID: 17608950 DOI: 10.1186/1743-422X-4-68] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
63 You D, Becnel D, Wang K, Ripple M, Daly M, Cormier SA. Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir Res 2006;7:107. [PMID: 16893457 DOI: 10.1186/1465-9921-7-107] [Cited by in Crossref: 85] [Cited by in F6Publishing: 82] [Article Influence: 5.3] [Reference Citation Analysis]
64 Eddens T, Parks OB, Williams JV. Neonatal Immune Responses to Respiratory Viruses. Front Immunol 2022;13:863149. [DOI: 10.3389/fimmu.2022.863149] [Reference Citation Analysis]
65 Matucci A, Vultaggio A, Maggi E, Kasujee I. Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question? Respir Res 2018;19:113. [PMID: 29879991 DOI: 10.1186/s12931-018-0813-0] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 15.8] [Reference Citation Analysis]
66 Li F, Zhu H, Sun R, Wei H, Tian Z. Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection. J Virol 2012;86:2251-8. [PMID: 22171263 DOI: 10.1128/JVI.06209-11] [Cited by in Crossref: 73] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
67 Espinoza JA, Bohmwald K, Céspedes PF, Riedel CA, Bueno SM, Kalergis AM. Modulation of host adaptive immunity by hRSV proteins. Virulence 2014;5:740-51. [PMID: 25513775 DOI: 10.4161/viru.32225] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
68 Ma Y, Jiang H, Wan Z, Li S, Li Y, Wang W, Jin X, Li Y, Zhang C. Evolutionary dynamics of group A and B respiratory syncytial virus in China, 2009-2018. Arch Virol 2021;166:2407-18. [PMID: 34131849 DOI: 10.1007/s00705-021-05139-2] [Reference Citation Analysis]
69 Hansbro NG, Horvat JC, Wark PA, Hansbro PM. Understanding the mechanisms of viral induced asthma: new therapeutic directions. Pharmacol Ther 2008;117:313-53. [PMID: 18234348 DOI: 10.1016/j.pharmthera.2007.11.002] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 6.1] [Reference Citation Analysis]
70 Hasegawa K, Jartti T, Mansbach JM, Laham FR, Jewell AM, Espinola JA, Piedra PA, Camargo CA Jr. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland. J Infect Dis 2015;211:1550-9. [PMID: 25425699 DOI: 10.1093/infdis/jiu658] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 11.0] [Reference Citation Analysis]
71 Oladokun R, Muloiwa R, Hsiao NY, Valley-Omar Z, Nuttall J, Eley B. Clinical characterisation and phylogeny of respiratory syncytial virus infection in hospitalised children at Red Cross War Memorial Children's Hospital, Cape Town. BMC Infect Dis 2016;16:236. [PMID: 27246848 DOI: 10.1186/s12879-016-1572-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
72 Elesela S, Morris SB, Narayanan S, Kumar S, Lombard DB, Lukacs NW. Sirtuin 1 regulates mitochondrial function and immune homeostasis in respiratory syncytial virus infected dendritic cells. PLoS Pathog 2020;16:e1008319. [PMID: 32106265 DOI: 10.1371/journal.ppat.1008319] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
73 Carrillo J, Izquierdo-Useros N, Ávila-Nieto C, Pradenas E, Clotet B, Blanco J. Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity. Biochem Biophys Res Commun 2021;538:187-91. [PMID: 33187644 DOI: 10.1016/j.bbrc.2020.10.108] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
74 Flatz L, Rieger T, Merkler D, Bergthaler A, Regen T, Schedensack M, Bestmann L, Verschoor A, Kreutzfeldt M, Brück W, Hanisch UK, Günther S, Pinschewer DD. T cell-dependence of Lassa fever pathogenesis. PLoS Pathog 2010;6:e1000836. [PMID: 20360949 DOI: 10.1371/journal.ppat.1000836] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 5.5] [Reference Citation Analysis]
75 Benmarzouk-Hidalgo OJ, Molina J, Cordero E, Merino L, Cabello V, Suarez-Artacho G, Sobrino M, Perez-Romero P. Asymptomatic and symptomatic respiratory virus infection detected in naso-pharyngeal swabs from solid organ transplant recipients early after transplantation. J Clin Virol 2011;52:276-7. [PMID: 21803649 DOI: 10.1016/j.jcv.2011.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
76 Bakalli I. Liver Dysfunction in Severe Sepsis from Respiratory Syncytial Virus. J Pediatr Intensive Care 2018;7:110-4. [PMID: 31073482 DOI: 10.1055/s-0037-1612609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
77 van Meel ER, den Dekker HT, Elbert NJ, Jansen PW, Moll HA, Reiss IK, de Jongste JC, Jaddoe VWV, Duijts L. A population-based prospective cohort study examining the influence of early-life respiratory tract infections on school-age lung function and asthma. Thorax 2018;73:167-73. [PMID: 29101282 DOI: 10.1136/thoraxjnl-2017-210149] [Cited by in Crossref: 35] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
78 Ward TM, Traina-Dorge V, Davis KA, Gray WL. Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic. J Gen Virol 2008;89:741-50. [PMID: 18272766 DOI: 10.1099/vir.0.83453-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
79 Persson BD, Jaffe AB, Fearns R, Danahay H. Respiratory syncytial virus can infect basal cells and alter human airway epithelial differentiation. PLoS One 2014;9:e102368. [PMID: 25033192 DOI: 10.1371/journal.pone.0102368] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
80 DeVincenzo JP, Wilkinson T, Vaishnaw A, Cehelsky J, Meyers R, Nochur S, Harrison L, Meeking P, Mann A, Moane E, Oxford J, Pareek R, Moore R, Walsh E, Studholme R, Dorsett P, Alvarez R, Lambkin-Williams R. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am J Respir Crit Care Med 2010;182:1305-14. [PMID: 20622030 DOI: 10.1164/rccm.201002-0221OC] [Cited by in Crossref: 212] [Cited by in F6Publishing: 122] [Article Influence: 17.7] [Reference Citation Analysis]
81 van Meel ER, den Dekker HT, Elbert NJ, Jansen PW, Moll HA, Reiss IK, de Jongste JC, Jaddoe VWV, Duijts L. A population-based prospective cohort study examining the influence of early-life respiratory tract infections on school-age lung function and asthma. Thorax 2018;73:167-73. [PMID: 29101282 DOI: 10.1136/thoraxjnl-2017-210149] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
82 van Meel ER, Jaddoe VWV, Bønnelykke K, de Jongste JC, Duijts L. The role of respiratory tract infections and the microbiome in the development of asthma: A narrative review. Pediatr Pulmonol 2017;52:1363-70. [PMID: 28869358 DOI: 10.1002/ppul.23795] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
83 Altamirano-Lagos MJ, Díaz FE, Mansilla MA, Rivera-Pérez D, Soto D, McGill JL, Vasquez AE, Kalergis AM. Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus. Front Microbiol 2019;10:873. [PMID: 31130923 DOI: 10.3389/fmicb.2019.00873] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
84 Sacco RE, McGill JL, Palmer MV, Lippolis JD, Reinhardt TA, Nonnecke BJ. Neonatal calf infection with respiratory syncytial virus: drawing parallels to the disease in human infants. Viruses 2012;4:3731-53. [PMID: 23342375 DOI: 10.3390/v4123731] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
85 Triantafilou K, Triantafilou M. Ion flux in the lung: virus-induced inflammasome activation. Trends Microbiol 2014;22:580-8. [PMID: 24986075 DOI: 10.1016/j.tim.2014.06.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
86 Schuurhof A, Bont L, Pennings JL, Hodemaekers HM, Wester PW, Buisman A, de Rond LC, Widjojoatmodjo MN, Luytjes W, Kimpen JL, Janssen R. Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection. J Virol 2010;84:9584-94. [PMID: 20592085 DOI: 10.1128/JVI.00302-10] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
87 Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, Velozo L, Jafri H, Chavez-Bueno S, Ogra PL, McKinney L, Reed JL, Welliver RC Sr. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 2007;195:1126-36. [PMID: 17357048 DOI: 10.1086/512615] [Cited by in Crossref: 280] [Cited by in F6Publishing: 266] [Article Influence: 18.7] [Reference Citation Analysis]
88 van Erp EA, Feyaerts D, Duijst M, Mulder HL, Wicht O, Luytjes W, Ferwerda G, van Kasteren PB. Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function. J Infect Dis 2019;219:723-33. [PMID: 30252097 DOI: 10.1093/infdis/jiy566] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
89 Yu X, Lakerveld AJ, Imholz S, Hendriks M, Ten Brink SCA, Mulder HL, de Haan K, Schepp RM, Luytjes W, de Jong MD, van Beek J, van Kasteren PB. Antibody and Local Cytokine Response to Respiratory Syncytial Virus Infection in Community-Dwelling Older Adults. mSphere 2020;5:e00577-20. [PMID: 32878928 DOI: 10.1128/mSphere.00577-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Jorquera PA, Tripp RA. Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus. Vaccines (Basel) 2016;4:E45. [PMID: 27918420 DOI: 10.3390/vaccines4040045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
91 Ederveen THA, Ferwerda G, Ahout IM, Vissers M, de Groot R, Boekhorst J, Timmerman HM, Huynen MA, van Hijum SAFT, de Jonge MI. Haemophilus is overrepresented in the nasopharynx of infants hospitalized with RSV infection and associated with increased viral load and enhanced mucosal CXCL8 responses. Microbiome 2018;6:10. [PMID: 29325581 DOI: 10.1186/s40168-017-0395-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
92 Cullen LM, Blanco JC, Morrison TG. Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein. J Transl Med 2015;13:350. [PMID: 26541285 DOI: 10.1186/s12967-015-0705-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
93 Khan NA, Singla M, Samal S, Lodha R, Medigeshi GR. Respiratory Syncytial Virus-Induced Oxidative Stress Leads to an Increase in Labile Zinc Pools in Lung Epithelial Cells. mSphere 2020;5:e00447-20. [PMID: 32461278 DOI: 10.1128/mSphere.00447-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
94 Loebbermann J, Durant L, Thornton H, Johansson C, Openshaw PJ. Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells. Proc Natl Acad Sci U S A 2013;110:2987-92. [PMID: 23382205 DOI: 10.1073/pnas.1217580110] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 5.3] [Reference Citation Analysis]
95 Walsh EE, Peterson DR, Kalkanoglu AE, Lee FE, Falsey AR. Viral shedding and immune responses to respiratory syncytial virus infection in older adults. J Infect Dis 2013;207:1424-32. [PMID: 23382572 DOI: 10.1093/infdis/jit038] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 9.3] [Reference Citation Analysis]
96 Dodd JS, Clark D, Muir R, Korpis C, Openshaw PJ. Endogenous IL-21 regulates pathogenic mucosal CD4 T-cell responses during enhanced RSV disease in mice. Mucosal Immunol 2013;6:704-17. [PMID: 23168836 DOI: 10.1038/mi.2012.108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
97 Beretta A, Cranage M, Zipeto D. Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis? Front Immunol 2020;11:567710. [PMID: 33178193 DOI: 10.3389/fimmu.2020.567710] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
98 Loebbermann J, Thornton H, Durant L, Sparwasser T, Webster KE, Sprent J, Culley FJ, Johansson C, Openshaw PJ. Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol 2012;5:161-72. [PMID: 22236998 DOI: 10.1038/mi.2011.62] [Cited by in Crossref: 115] [Cited by in F6Publishing: 115] [Article Influence: 11.5] [Reference Citation Analysis]
99 Roumanes D, Falsey AR, Quataert S, Secor-Socha S, Lee FE, Yang H, Bandyopadhyay S, Holden-Wiltse J, Topham DJ, Walsh EE. T-Cell Responses in Adults During Natural Respiratory Syncytial Virus Infection. J Infect Dis 2018;218:418-28. [PMID: 29920599 DOI: 10.1093/infdis/jiy016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
100 Rothoeft T, Fischer K, Zawatzki S, Schulz V, Schauer U, Körner Rettberg C. Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus. Clin Exp Immunol 2007;150:263-73. [PMID: 17892510 DOI: 10.1111/j.1365-2249.2007.03497.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
101 Samadizadeh S, Arabi MS, Yasaghi M, Salimi V, Tabarraei A, Moradi A, Tahamtan A. Anti-inflammatory effects of curcumin-loaded niosomes on respiratory syncytial virus infection in a mice model. J Med Microbiol 2022;71. [PMID: 35417322 DOI: 10.1099/jmm.0.001525] [Reference Citation Analysis]
102 Olivier AK, Gallup JM, van Geelen A, Ackermann MR. Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses. Exp Lung Res 2011;37:131-43. [PMID: 21309731 DOI: 10.3109/01902148.2010.484518] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
103 Boukhvalova MS, Yim KC, Prince GA, Blanco JC. Methods for monitoring dynamics of pulmonary RSV replication by viral culture and by real-time reverse transcription-PCR in vivo: Detection of abortive viral replication. Curr Protoc Cell Biol 2010;Chapter 26:Unit26.6. [PMID: 20235102 DOI: 10.1002/0471143030.cb2606s46] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
104 Qin L, Hu CP, Feng JT, Xia Q. Activation of lymphocytes induced by bronchial epithelial cells with prolonged RSV infection. PLoS One 2011;6:e27113. [PMID: 22216085 DOI: 10.1371/journal.pone.0027113] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
105 Liu Y, Qi X, Li G, Sowa G. Caveolin-2 deficiency induces a rapid anti-tumor immune response prior to regression of implanted murine lung carcinoma tumors. Sci Rep 2019;9:18970. [PMID: 31831780 DOI: 10.1038/s41598-019-55368-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
106 Martinez ME, Capella Gonzalez C, Huey D, Peeples ME, McCarty D, Niewiesk S. Immunogenicity and inflammatory properties of respiratory syncytial virus attachment G protein in cotton rats. PLoS One 2021;16:e0246770. [PMID: 33600439 DOI: 10.1371/journal.pone.0246770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Glaser L, Coulter PJ, Shields M, Touzelet O, Power UF, Broadbent L. Airway Epithelial Derived Cytokines and Chemokines and Their Role in the Immune Response to Respiratory Syncytial Virus Infection. Pathogens 2019;8:E106. [PMID: 31331089 DOI: 10.3390/pathogens8030106] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
108 Lee JS, Cho MK, Hwang HS, Ko EJ, Lee YN, Kwon YM, Kim MC, Kim KH, Lee YT, Jung YJ, Kang SM. Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses. J Interferon Cytokine Res 2014;34:902-14. [PMID: 25051168 DOI: 10.1089/jir.2013.0093] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
109 McDonald JU, Kaforou M, Clare S, Hale C, Ivanova M, Huntley D, Dorner M, Wright VJ, Levin M, Martinon-Torres F, Herberg JA, Tregoning JS. A Simple Screening Approach To Prioritize Genes for Functional Analysis Identifies a Role for Interferon Regulatory Factor 7 in the Control of Respiratory Syncytial Virus Disease. mSystems 2016;1:e00051-16. [PMID: 27822537 DOI: 10.1128/mSystems.00051-16] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
110 Rosenberg HF, Dyer KD, Domachowske JB. Respiratory viruses and eosinophils: exploring the connections. Antiviral Res 2009;83:1-9. [PMID: 19375458 DOI: 10.1016/j.antiviral.2009.04.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
111 Benoit A, Huang Y, Proctor J, Rowden G, Anderson R. Effects of alveolar macrophage depletion on liposomal vaccine protection against respiratory syncytial virus (RSV). Clin Exp Immunol 2006;145:147-54. [PMID: 16792685 DOI: 10.1111/j.1365-2249.2006.03114.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
112 Munoz FM, Cramer JP, Dekker CL, Dudley MZ, Graham BS, Gurwith M, Law B, Perlman S, Polack FP, Spergel JM, Van Braeckel E, Ward BJ, Didierlaurent AM, Lambert PH; Brighton Collaboration Vaccine-associated Enhanced Disease Working Group. Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2021;39:3053-66. [PMID: 33637387 DOI: 10.1016/j.vaccine.2021.01.055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
113 Watkiss ER, Shrivastava P, Arsic N, Gomis S, van Drunen Littel-van den Hurk S. Innate and adaptive immune response to pneumonia virus of mice in a resistant and a susceptible mouse strain. Viruses 2013;5:295-320. [PMID: 23337382 DOI: 10.3390/v5010295] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
114 Letellier C, Boxus M, Rosar L, Toussaint JF, Walravens K, Roels S, Meyer G, Letesson JJ, Kerkhofs P. Vaccination of calves using the BRSV nucleocapsid protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology. Vaccine 2008;26:4840-8. [PMID: 18644416 DOI: 10.1016/j.vaccine.2008.06.100] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
115 Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 2010;23:74-98. [PMID: 20065326 DOI: 10.1128/CMR.00032-09] [Cited by in Crossref: 394] [Cited by in F6Publishing: 264] [Article Influence: 32.8] [Reference Citation Analysis]
116 Park YM, Bochner BS. Eosinophil survival and apoptosis in health and disease. Allergy Asthma Immunol Res 2010;2:87-101. [PMID: 20358022 DOI: 10.4168/aair.2010.2.2.87] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 6.6] [Reference Citation Analysis]
117 Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, Sly PD. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007;119:1105-10. [PMID: 17353039 DOI: 10.1016/j.jaci.2006.12.669] [Cited by in Crossref: 501] [Cited by in F6Publishing: 465] [Article Influence: 33.4] [Reference Citation Analysis]